DaVita (DVA) Misses Q3 EPS by 31c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
DaVita (DVA) says it's grateful that Californians voted down Proposition 8
November 7, 2018 8:29 AM ESTDaVita Kidney Care, a division of DaVita Inc. (NYSE: DVA), and a leading provider of kidney care services in the United States, issued the following statement.
We are... More
Health stocks up on U.S. vote; insurers hit records
November 7, 2018 4:16 AM ESTBy Ben Hirschler and Manas Mishra
(Reuters) - Shares in drugmakers and U.S. health insurers rallied on Wednesday, after election results delivered a split Congress that is unlikely to significantly cut government healthcare programs or reduce drug prices in the world's biggest and most profitable market.
Republicans lost control of the House of Representatives to the Democrats in Tuesday's elections, a setback for President Donald Trump, but increased their grip on the Senate, signaling likely policy gridlock in Washington.
While both parties agree on the need to bring down healthcare costs,... More
